| Title |
Inhaled corticosteroids for cystic fibrosis.
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2014
|
| DOI | 10.1002/14651858.cd001915.pub4 |
| Pubmed ID | |
| Authors |
Ian M Balfour-Lynn, Karen Welch, Balfour-Lynn IM, Welch K, Balfour-Lynn, Ian M, Welch, Karen |
| Abstract |
Reduction of lung inflammation is one of the goals of cystic fibrosis therapy. Inhaled corticosteroids are often used to treat children and adults with cystic fibrosis. The rationale for this is their potential to reduce lung damage arising from inflammation, as well as their effect on symptomatic wheezing. It is important to establish the current level of evidence for the risks and benefits of inhaled corticosteroids, especially in the light of their known adverse effects on growth. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 3% |
| Unknown | 37 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 8 | 21% |
| Student > Master | 7 | 18% |
| Student > Bachelor | 5 | 13% |
| Student > Postgraduate | 4 | 11% |
| Other | 3 | 8% |
| Other | 4 | 11% |
| Unknown | 7 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 45% |
| Biochemistry, Genetics and Molecular Biology | 3 | 8% |
| Psychology | 3 | 8% |
| Agricultural and Biological Sciences | 2 | 5% |
| Mathematics | 1 | 3% |
| Other | 4 | 11% |
| Unknown | 8 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2014.
All research outputs
#2,002,876
of 23,310,485 outputs
Outputs from Cochrane database of systematic reviews
#4,381
of 12,444 outputs
Outputs of similar age
#23,741
of 256,486 outputs
Outputs of similar age from Cochrane database of systematic reviews
#86
of 234 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,444 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.8. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 256,486 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.